A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy. [electronic resource]
Producer: 20210218Description: 1660-1671 p. digitalISSN:- 2050-7518
- Animals
- Antineoplastic Agents -- chemistry
- Biocompatible Materials -- chemistry
- Cell Line, Tumor
- Cell Survival -- drug effects
- Doxorubicin -- chemistry
- Drug Carriers -- chemistry
- Drug Liberation
- Endocytosis
- Folic Acid -- analogs & derivatives
- Humans
- Hydrogen-Ion Concentration
- Male
- Mice
- Mice, Nude
- Microscopy, Confocal
- Nanodiamonds -- chemistry
- Neoplasms -- drug therapy
- Polyethylene Glycols -- chemistry
- Theranostic Nanomedicine
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.